Translating genomics research into the improvement of patient outcomes requires the development of robust assays that can perform with the accuracy, sensitivity, and reproducibility required for clinical use. A crucial component of this assay development is the choice of reference material, which ensures the test is performing as expected and provides confidence in the results that will be used to monitor patient treatment and guide clinical outcomes.

To learn how LGC Clinical Diagnostics | SeraCare is helping assay developers keep up with the rapidly evolving field of cancer diagnostics, download the white paper today by filling out the form.